Skip to content

Relay Therapeutics

US · RLAY #2273 by market cap Listed 2020
16.12 +0.21 +1.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About Relay Therapeutics

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.

Founded
2015
CEO
Dr. Sanjiv K. Patel, M.B.B.S.,M.D.
Employees
192
Headquarters
Cambridge, Massachusetts, United States of America
Fiscal year end
12-31
Website
relaytx.com

Company profile

Exchange
US
Symbol
RLAY
Market-cap rank
#2273
Listing date
2020-07-16
Market cap
3.56B
Float cap
2.49B
Shares out
220.96M
Float shares
154.74M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Relay Therapeutics discussion 0 comments

Add a comment